-
1
-
-
67650457718
-
Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit
-
Department of Pulmonary and Critical Care Medicine, Washington Hospital Center, Washington DC, USA. afshorratmail.dnamail.com.
-
Shorr AF. Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit. Crit Care Med. 2009;37:1463-9. Department of Pulmonary and Critical Care Medicine, Washington Hospital Center, Washington DC, USA. afshorratmail.dnamail.com.
-
(2009)
Crit Care Med
, vol.37
, pp. 1463-1469
-
-
Shorr, A.F.1
-
2
-
-
57749107808
-
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America
-
Division of Geographic Medicine and Infectious Diseases, Tufts University and Tufts Medical Center, Boston, Massachusetts 02111, USA. hboucherattuftsmedicalcenter.org.
-
Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1-12. Division of Geographic Medicine and Infectious Diseases, Tufts University and Tufts Medical Center, Boston, Massachusetts 02111, USA. hboucherattuftsmedicalcenter.org.
-
(2009)
Clin Infect Dis
, vol.48
, pp. 1-12
-
-
Boucher, H.W.1
Talbot, G.H.2
Bradley, J.S.3
Edwards, J.E.4
Gilbert, D.5
Rice, L.B.6
-
3
-
-
33845903833
-
Drugs for bad bugs: confronting the challenges of antibacterial discovery
-
Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Discov. 2007;6:29-40. Infectious Diseases Centre of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, USA.
-
(2007)
Nat Rev Discov
, vol.6
, pp. 29-40
-
-
Payne, D.J.1
Gwynn, M.N.2
Holmes, D.J.3
Pompliano, D.L.4
-
4
-
-
84867655439
-
Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?
-
Bergen PJ, Landersdorfer CB, Zhang J, Zhao M, Lee HJ, Nation RL, et al. Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new? Diagn Microbiol Infect Dis. 2012;74:213-23. Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.: Elsevier Inc.
-
(2012)
Diagn Microbiol Infect Dis
, vol.74
, pp. 213-223
-
-
Bergen, P.J.1
Landersdorfer, C.B.2
Zhang, J.3
Zhao, M.4
Lee, H.J.5
Nation, R.L.6
-
5
-
-
79952155978
-
Pharmacokinetic evaluation of colistin sodium
-
Intensive Care Unit, Henry Dunant Hospital, 107 Mesogeion Ave, 11528, Athens, Greece. amichalopoulosathol.gr.
-
Michalopoulos AS, Karatza DC, Gregorakos L. Pharmacokinetic evaluation of colistin sodium. Expert Opin Drug Metab Toxicol. 2011;7:245-55. Intensive Care Unit, Henry Dunant Hospital, 107 Mesogeion Ave, 11528, Athens, Greece. amichalopoulosathol.gr.
-
(2011)
Expert Opin Drug Metab Toxicol
, vol.7
, pp. 245-255
-
-
Michalopoulos, A.S.1
Karatza, D.C.2
Gregorakos, L.3
-
6
-
-
79959248672
-
Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients
-
Garonzik SM, Li J, Thamlikitkul V, Paterson DL, Shoham S, Jacob J, et al. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother. 2011;55:3284-94. School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, SUNY, Buffalo, New York, USA.
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 3284-3294
-
-
Garonzik, S.M.1
Li, J.2
Thamlikitkul, V.3
Paterson, D.L.4
Shoham, S.5
Jacob, J.6
-
7
-
-
83655164078
-
Colistin: new lessons on an old antibiotic
-
Internal Medicine E, Rabin Medical Centre, Beilinson Hospital, Petah Tikva, Israel. dafna.yahavatgmail.com: European Society of Clinical Microbiology and Infectious Diseases.
-
Yahav D, Farbman L, Leibovici L, Paul M. Colistin: new lessons on an old antibiotic. Clin Microbiol Infect. 2012;18:18-29. Internal Medicine E, Rabin Medical Centre, Beilinson Hospital, Petah Tikva, Israel. dafna.yahavatgmail.com: European Society of Clinical Microbiology and Infectious Diseases. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22168320.
-
(2012)
Clin Microbiol Infect
, vol.18
, pp. 18-29
-
-
Yahav, D.1
Farbman, L.2
Leibovici, L.3
Paul, M.4
-
8
-
-
72449141579
-
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
-
Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 15 123 Marousi, Athens, Greece. m.falagasataibs.gr: Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
-
Falagas ME, Rafailidis PI, Ioannidou E, Alexiou VG, Matthaiou DK, Karageorgopoulos DE, et al. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents. 2010;35:194-9. Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 15 123 Marousi, Athens, Greece. m.falagasataibs.gr: Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
-
(2010)
Int J Antimicrob Agents
, vol.35
, pp. 194-199
-
-
Falagas, M.E.1
Rafailidis, P.I.2
Ioannidou, E.3
Alexiou, V.G.4
Matthaiou, D.K.5
Karageorgopoulos, D.E.6
-
9
-
-
70350164591
-
Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections
-
Dept. of Internal Medicine and Infectious Diseases, Hospital del Mar, Autonomous University of Barcelona, Barcelona, Spain. 95422atimas.imim.es.
-
Montero M, Horcajada JP, Sorli L, Alvarez-Lerma F, Grau S, Riu M, et al. Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections. Infection. 2009;37:461-5. Dept. of Internal Medicine and Infectious Diseases, Hospital del Mar, Autonomous University of Barcelona, Barcelona, Spain. 95422atimas.imim.es.
-
(2009)
Infection
, vol.37
, pp. 461-465
-
-
Montero, M.1
Horcajada, J.P.2
Sorli, L.3
Alvarez-Lerma, F.4
Grau, S.5
Riu, M.6
-
10
-
-
84861503214
-
High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study
-
Dalfino L, Puntillo F, Mosca A, Monno R, Spada ML, Coppolecchia S, et al. High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study. Clin Infect Dis. 2012;54:1720-6. Anesthesia and Intensive Care Unit, Department of Emergeny and Organ Transplantion.
-
(2012)
Clin Infect Dis
, vol.54
, pp. 1720-1726
-
-
Dalfino, L.1
Puntillo, F.2
Mosca, A.3
Monno, R.4
Spada, M.L.5
Coppolecchia, S.6
-
11
-
-
77953705195
-
Effectiveness and safety of colistin: prospective comparative cohort study
-
Unit of Infectious Diseases, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel. paulmatpost.tau.ac.il.
-
Paul M, Bishara J, Levcovich A, Chowers M, Goldberg E, Singer P, et al. Effectiveness and safety of colistin: prospective comparative cohort study. J Antimicrob Chemother. 2010;65:1019-27. Unit of Infectious Diseases, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel. paulmatpost.tau.ac.il. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20299494.
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 1019-1027
-
-
Paul, M.1
Bishara, J.2
Levcovich, A.3
Chowers, M.4
Goldberg, E.5
Singer, P.6
-
12
-
-
84963971763
-
Colistin: understanding and applying recent pharmacokinetic advances
-
Ortwine JK, Kaye KS, Li J, Pogue JM. Colistin: understanding and applying recent pharmacokinetic advances. Pharmacotherapy. 2015;35:11-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25187500.
-
(2015)
Pharmacotherapy
, vol.35
, pp. 11-16
-
-
Ortwine, J.K.1
Kaye, K.S.2
Li, J.3
Pogue, J.M.4
-
13
-
-
0036176161
-
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification
-
Foundation NK. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-266.
-
(2002)
Am J Kidney Dis
, vol.39
, pp. S1-266
-
-
Foundation, N.K.1
-
14
-
-
0027940266
-
Validation of a combined comorbidity index
-
Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245-51. Department of Medicine, Cornell Arthritis and Musculoskeletal Disease Center, Hospital for Special Surgery, New York, NY, USA.
-
(1994)
J Clin Epidemiol
, vol.47
, pp. 1245-1251
-
-
Charlson, M.1
Szatrowski, T.P.2
Peterson, J.3
Gold, J.4
-
16
-
-
44449164571
-
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting
-
National Healthcare Safety Network, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. thoranatcdc.gov.
-
Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-32. National Healthcare Safety Network, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. thoranatcdc.gov. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18538699.
-
(2008)
Am J Infect Control
, vol.36
, pp. 309-332
-
-
Horan, T.C.1
Andrus, M.2
Dudeck, M.A.3
-
17
-
-
0026874127
-
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.
-
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 1992;20:864-74.
-
(1992)
Crit. Care Med.
, vol.20
, pp. 864-874
-
-
-
18
-
-
84857646835
-
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
-
Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268-81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21793988.
-
(2012)
Clin Microbiol Infect
, vol.18
, pp. 268-281
-
-
Magiorakos, A.-P.1
Srinivasan, A.2
Carey, R.B.3
Carmeli, Y.4
Falagas, M.E.5
Giske, C.G.6
-
19
-
-
0035949823
-
A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography
-
Li J, Milne RW, Nation RL, Turnidge JD, Coulthard K, Johnson DW. A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography. J Chromatogr Biomed Sci Appl. 2001;761:167-75. Centre for Pharmaceutical Research, University of South Australia, Adelaide Australia.
-
(2001)
J Chromatogr Biomed Sci Appl
, vol.761
, pp. 167-175
-
-
Li, J.1
Milne, R.W.2
Nation, R.L.3
Turnidge, J.D.4
Coulthard, K.5
Johnson, D.W.6
-
20
-
-
84882539817
-
Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study
-
Sorlí L, Luque S, Grau S, Berenguer N, Segura C, Montero MM, et al. Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study. BMC Infect Dis. 2013;13:380. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3765824&tool=pmcentrez&rendertype=abstract.
-
(2013)
BMC Infect Dis
, vol.13
, pp. 380
-
-
Sorlí, L.1
Luque, S.2
Grau, S.3
Berenguer, N.4
Segura, C.5
Montero, M.M.6
-
21
-
-
83655167235
-
Colistin pharmacokinetics: the fog is lifting
-
Couet W, Gregoire N, Marchand S, Mimoz O. Colistin pharmacokinetics: the fog is lifting. Clin Microbiol Infect. 2012;18:30-9. Inserm ERI-23, CHU, Service de Toxicologie et Pharmacocinetique, UFR Medecine-Pharmacie, Universite de Poitiers Intensive Care Unit, University Hospital of Poitiers, Poitiers, France.: European Society of Clinical Microbiology and Infectious Diseases.
-
(2012)
Clin Microbiol Infect
, vol.18
, pp. 30-39
-
-
Couet, W.1
Gregoire, N.2
Marchand, S.3
Mimoz, O.4
-
22
-
-
10244236377
-
Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
-
Department of Intensive Care and Medicine, Austin Health, Melbourne, Australia. rinaldo.bellomoataustin.org.au.
-
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, ADQI. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204-12. Department of Intensive Care and Medicine, Austin Health, Melbourne, Australia. rinaldo.bellomoataustin.org.au.
-
(2004)
Crit Care
, vol.8
, pp. R204-R212
-
-
Bellomo, R.1
Ronco, C.2
Kellum, J.A.3
Mehta, R.L.4
Palevsky, P.5
-
23
-
-
0032939527
-
Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
-
Hospital Infection Control Department, Hospital das Clinicas, Faculdade de Medicina, University of Sao Paulo, SP, Brazil. nivelatusp.br.
-
Levin AS, Barone AA, Penco J, Santos MV, Marinho IS, Arruda EA, et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis. 1999;28:1008-11. Hospital Infection Control Department, Hospital das Clinicas, Faculdade de Medicina, University of Sao Paulo, SP, Brazil. nivelatusp.br.
-
(1999)
Clin Infect Dis
, vol.28
, pp. 1008-1011
-
-
Levin, A.S.1
Barone, A.A.2
Penco, J.3
Santos, M.V.4
Marinho, I.S.5
Arruda, E.A.6
-
24
-
-
73549097280
-
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
-
Cheng CY, Sheng WH, Wang JT, Chen YC, Chang SC. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections. Int J Antimicrob Agents. 2010;35:297-300. Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.: Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
-
(2010)
Int J Antimicrob Agents
, vol.35
, pp. 297-300
-
-
Cheng, C.Y.1
Sheng, W.H.2
Wang, J.T.3
Chen, Y.C.4
Chang, S.C.5
-
25
-
-
84991212329
-
Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
-
Intensive Care Unit B, Athens Trauma Hospital KAT, Athens, Greece. nikolaos_markouathotmail.com.
-
Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, et al. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care. 2003;7:R78-83. Intensive Care Unit B, Athens Trauma Hospital KAT, Athens, Greece. nikolaos_markouathotmail.com.
-
(2003)
Crit Care
, vol.7
, pp. R78-83
-
-
Markou, N.1
Apostolakos, H.2
Koumoudiou, C.3
Athanasiou, M.4
Koutsoukou, A.5
Alamanos, I.6
-
26
-
-
67749145541
-
Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria
-
4th Department of Internal Medicine, Attikon University General Hospital, Haidari 12462, Greece. dplachatmed.uoa.gr.
-
Plachouras D, Karvanen M, Friberg LE, Papadomichelakis E, Antoniadou A, Tsangaris I, et al. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother. 2009;53:3430-6. 4th Department of Internal Medicine, Attikon University General Hospital, Haidari 12462, Greece. dplachatmed.uoa.gr.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 3430-3436
-
-
Plachouras, D.1
Karvanen, M.2
Friberg, L.E.3
Papadomichelakis, E.4
Antoniadou, A.5
Tsangaris, I.6
-
27
-
-
45149094778
-
Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study
-
Markou N, Markantonis SL, Dimitrakis E, Panidis D, Boutzouka E, Karatzas S, et al. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study. Clin Ther. 2008;30:143-51. Available from: http://www.sciencedirect.com/science/article/pii/S0149291808000635.
-
(2008)
Clin Ther
, vol.30
, pp. 143-151
-
-
Markou, N.1
Markantonis, S.L.2
Dimitrakis, E.3
Panidis, D.4
Boutzouka, E.5
Karatzas, S.6
-
28
-
-
84874106093
-
Clinical and microbiological efficacy and toxicity of colistin in patients infected with multidrug-resistant gram-negative pathogens
-
Infectious Diseases and Clinical Microbiology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey. ruhsar6atyahoo.com.
-
Yilmaz GR, Bastug AT, But A, Yildiz S, Yetkin MA, Kanyilmaz D, et al. Clinical and microbiological efficacy and toxicity of colistin in patients infected with multidrug-resistant gram-negative pathogens. J Infect Chemother. 2013;19:57-62. Infectious Diseases and Clinical Microbiology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey. ruhsar6atyahoo.com.
-
(2013)
J Infect Chemother
, vol.19
, pp. 57-62
-
-
Yilmaz, G.R.1
Bastug, A.T.2
But, A.3
Yildiz, S.4
Yetkin, M.A.5
Kanyilmaz, D.6
-
29
-
-
84899456465
-
Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria
-
Zaidi ST, Al Omran S, Al Aithan AS, Al Sultan M. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria. J Clin Pharm Ther. 2014;39(3):272-6.
-
(2014)
J Clin Pharm Ther
, vol.39
, Issue.3
, pp. 272-276
-
-
Zaidi, S.T.1
Omran, S.2
Aithan, A.S.3
Sultan, M.4
-
30
-
-
84898007596
-
Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia
-
Khawcharoenporn T, Pruetpongpun N, Tiamsak P, Rutchanawech S, Mundy LM, Apisarnthanarak A. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia. Int J Antimicrob Agents. 2014;43:378-82.
-
(2014)
Int J Antimicrob Agents
, vol.43
, pp. 378-382
-
-
Khawcharoenporn, T.1
Pruetpongpun, N.2
Tiamsak, P.3
Rutchanawech, S.4
Mundy, L.M.5
Apisarnthanarak, A.6
-
31
-
-
84874113830
-
Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality
-
Peña C, Gómez-Zorrilla S, Oriol I, Tubau F, Dominguez MA, Pujol M, et al. Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality. Eur J Clin Microbiol Infect Dis. 2013;32:413-20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23344827.
-
(2013)
Eur J Clin Microbiol Infect Dis
, vol.32
, pp. 413-420
-
-
Peña, C.1
Gómez-Zorrilla, S.2
Oriol, I.3
Tubau, F.4
Dominguez, M.A.5
Pujol, M.6
-
32
-
-
84940001276
-
Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes
-
Kwon KH, Oh JY, Yoon Y-S, Jeong Y-J, Kim KS, Shin SJ, et al. Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes. Int J Antimicrob Agents. 2015;45(6):605-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25772644.
-
(2015)
Int J Antimicrob Agents
, vol.45
, Issue.6
, pp. 605-609
-
-
Kwon, K.H.1
Oh, J.Y.2
Yoon, Y.-S.3
Jeong, Y.-J.4
Kim, K.S.5
Shin, S.J.6
-
33
-
-
84963684468
-
Antimicrob Agents Chemother
-
Rigatto MH, Oliveira MS, Perdigão-Neto LV, Levin AS, Carrilho CM, Tanita MT, et al. Antimicrob Agents Chemother. 2016;60:2443-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26856846.
-
(2016)
, vol.60
, pp. 2443-2449
-
-
Rigatto, M.H.1
Oliveira, M.S.2
Perdigão-Neto, L.V.3
Levin, A.S.4
Carrilho, C.M.5
Tanita, M.T.6
-
34
-
-
84979197352
-
Colistin for lung infection: an update
-
Gurjar M. Colistin for lung infection: an update. J intensive care. 2015;3:3. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4336271&tool=pmcentrez&rendertype=abstract.
-
(2015)
J intensive care
, vol.3
, pp. 3
-
-
Gurjar, M.1
|